Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.83 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.83 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.83 |
| ▸ | SRC | P12931 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.83 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.83 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.83 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.83 |
| ▸ | LDHA | P00338 | 1/20 | 0.83 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.83 |
| ▸ | FBP1 | P09467 | 1/20 | 0.83 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.83 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.83 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.83 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.83 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.83 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.83 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.83 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.83 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15498428 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL31266503 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL29431883 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL42104 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL21067751 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL23867092 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| Water SCHEMBL17159664 | 0.99 | P2RY1 (0.81) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| Sulfuric Acid SCHEMBL11187808 | 0.96 | P2RY1 (0.77) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL4360139 | 0.95 | P2RY1 (0.75) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL24059958 | 0.94 | ADORA1 (0.76) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2501816-A1 | PLANTS WITH INCREASED YIELD | BASF Plant Science Company GmbH (DE) | 2012-09-26 | — | — | EP | claimed |
| US-20120227134-A1 | Plants with Increased Yield | BASF PLANT SCIENCE COMPANY GMBH (DE) | 2012-09-06 | — | — | US | claimed |
| WO-2011061656-A1 | PLANTS WITH INCREASED YIELD | BASF PLANT SCIENCE COMPANY GMBH (DE) | 2011-05-26 | — | — | WO | claimed |
| EP-2312319-A1 | Process of screening a molecule as a candidate drug for the treatment of bipolar disorder | INSTITUT PASTEUR (FR) | 2011-04-20 | — | — | EP | claimed |
| US-7655445-B2 | Synthesis of N-deacetylate N-sulfate derivatives of non-sulfated N-acetyl heparosan (HS) polysaccharides; rapid synthesis; high product yield | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-02-02 | — | — | US | claimed |
| US-20100008894-A1 | Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder | INSTITUTE PASTEUR (FR) | 2010-01-14 | — | — | US | claimed |
| EP-1934617-A1 | PROCESS OF SCREENING A MOLECULE AS A CANDIDATE DRUG FOR THE TREATMENT OF BIPOLAR DISORDER | INSTITUT PASTEUR (FR) | 2008-06-25 | — | — | EP | claimed |
| WO-2007039500-A1 | PROCESS OF SCREENING A MOLECULE AS A CANDIDATE DRUG FOR THE TREATMENT OF BIPOLAR DISORDER | INSTITUT PASTEUR (FR) | 2007-04-12 | — | — | WO | claimed |
| EP-1767946-A1 | Process of screening a molecule as a candidate drug for the treatment of bipolar disorder | INSTITUT PASTEUR (FR) | 2007-03-28 | — | — | EP | claimed |
| US-20250243524-A1 | METHOD FOR PRODUCING SULFATED POLYSACCHARIDE AND METHOD FOR PRODUCING PAPS | KIRIN BIOMATERIALS CO., LTD. (JP) | 2025-07-31 | — | — | US | disclosed |
| US-12359232-B2 | Biological processes for the production of aryl sulfates | CYSBIO APS (DK) | 2025-07-15 | — | — | US | disclosed |
| US-12291504-B2 | Small molecule inhibition of sulfotransferase SULT1A3 | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-05-06 | — | — | US | disclosed |
| US-12264350-B2 | Method for producing sulfated polysaccharide and method for producing PAPS | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2025-04-01 | — | — | US | disclosed |
| EP-3663406-B1 | BIOLOGICAL PROCESSES FOR THE PRODUCTION OF ARYL SULFATES | CYSBIO APS (DK) | 2025-02-26 | — | — | EP | disclosed |
| US-5741668-A | SYNTHESIZING COELENTERAZINE, A BIOLUMINESCENT COMPOUND | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 1998-04-21 | — | — | US | disclosed |
| US-5716836-A | Anti-sulfated tyrosine antibody specific for sulfated tyrosine, process for producing the same, and hybridoma capable of producing anti-sulfated tyrosine monoclonal antibody specific for sulfated tyrosine | UNITIKA LTD. (JP) | 1998-02-10 | — | — | US | disclosed |
| EP-0817862-A1 | ONE-POT ENZYMATIC SULFATION PROCESS USING 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE AND RECYCLED PHOSPHORYLATED ADENOSINE INTERMEDIATES | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996029424-A9 | ONE-POT ENZYMATIC SULFATION PROCESS USING 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE AND RECYCLED PHOSPHORYLATED ADENOSINE INTERMEDIATES | — | 1996-11-21 | — | — | WO | disclosed |
| WO-1996029424-A1 | ONE-POT ENZYMATIC SULFATION PROCESS USING 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE AND RECYCLED PHOSPHORYLATED ADENOSINE INTERMEDIATES | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-09-26 | — | — | WO | disclosed |
| WO-1995021191-A1 | BIOLUMINESCENT INDICATOR BASED UPON THE EXPRESSION OF A GENE FOR A MODIFIED GREEN-FLUORESCENT PROTEIN | WARD WILLIAM (US) | 1995-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12291504-B2 | Small molecule inhibition of sulfotransferase SULT1A3 | SULT1A1, SULT2A1, SULT1E1 | P2RY1 4560/4885P2RY2 4549/4885ADORA1 3496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.